Several mortality-relevant biomarkers have been identified in patients with sepsis, and these markers represent a promising avenue for improving sepsis management, such as C-reactive protein, procalcitonin, presepsin, protein C, monocyte chemo-attractant protein-1, and angiotensin [3–7]. The gene discussed is CRP; the disease is Sepsis.